BN · rank #11 · 2026-07-24
FII
PARIS · EUR · $3.31B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | -0.28 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +9.6% |
| Forward net margin Consensus forward net margin. | +8.6% |
| Net margin TTM Trailing twelve month net margin. | +7.7% |
| Margin expansion Forward minus trailing net margin (percentage points). | +0.9% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | 0.99 |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 3.35× |
| Analyst upside Spread between the consensus 12m target and the current price. | +15.0% |
| Last EPS surprise Most recent reported EPS versus consensus. | — |
| Market cap (USD) | $3.31B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Lisi S.A. designs and manufactures high-reliability fasteners and structural components for leading global aerospace and defense OEMs, which contribute approximately two-thirds of group revenue after the 2025 divestment of its medical division.
Rationale
LISI is highly leveraged to the european_defense_ammunition_bottleneck macro theme through its supply of critical fasteners and components to major defense programs like the Caesar artillery and Rafale, which is validated by a strong H1 2026 earnings beat.
Material risks
- 1High customer concentration exposes LISI to severe volume disruptions if key aerospace or defense OEMs decide to build precision fastener capabilities in-house.
- 2Structural softness in the global automotive division and transactional currency headwinds continue to drag on group-level margins and limit overall pricing power.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.